ELYRIA, Ohio – Invacare announced May 13 that the Food and Drug Administration (FDA) has approved the first of three audits, allowing the company to resume certain production at its Taylor Street facility.
ELYRIA, Ohio – Invacare in April submitted two audits to the Food and Drug Administration (FDA) for approval, but it’s an accomplishment that has been overshadowed by another poor earnings showing.
SAN DIEGO – Despite pervasive reimbursement pressures, ResMed officials have reported solid earnings for the third quarter and outlined “major growth horizons” for the company’s future.
SAN DIEGO – The Food and Drug Administration (FDA) has cleared ResMed’s variable positive airway pressure (VPAP) device for the treatment of COPD, according to a press release.
ELYRIA, Ohio – Invacare will release its financial results for the first quarter of 2013 before the market opens on Thursday, April 25, according to a press release. In a conference call scheduled that same day at 8:30 a.m.
ELYRIA, Ohio – In a big sign that an agreement with the Food and Drug Administration (FDA) is dampening sales, Invacare has announced that it has laid off an additional 68 employees at its manufacturing facility on Taylor Street.
ELYRIA, Ohio – Employees in some departments at Invacare’s Taylor Street facility will soon work three-day instead of five-day shifts, according to an article from The Morning Journal, a newspaper based in Lorain, Ohio.
ELYRIA, Ohio – It may be an uphill battle for Invacare to get new customers into complex power wheelchairs under an agreement it has with the Food and Drug Administration (FDA).
